Risklick

Risklick is at the forefront of transforming clinical trial protocol development through its AI-driven platform, Protocol AI. The company serves experts in the clinical trial industry, providing them with tools to conduct systematic analyses of global data, including historical trial synopses, protocols, linked publications, and regulatory decisions. Operating in the healthcare and pharmaceutical sectors, Risklick's business model revolves around offering a co-pilot software that enables internal and external teams to collaborate efficiently on one platform. By leveraging historical data, the platform allows users to develop state-of-the-art trial protocols, select appropriate parameters, and automate the writing of tailored protocols. This approach not only accelerates decision-making processes but also ensures trials are conducted faster, cheaper, and safer, ultimately paving the way for medical innovation. Risklick generates revenue by providing this specialized software to clinical trial experts, enhancing their ability to make informed, evidence-based strategic decisions. Keywords: AI, clinical trials, protocol development, healthcare, pharmaceutical, data analysis, collaboration, automation, strategic decisions, medical innovation.